Editas Medicine Inc, Apellis Pharmaceuticals Inc and Rigel Pharmaceuticals Inc at Citi Biotech Conference Transcript
Let's kick it off. So welcome back everyone for Day 2 of the Citi Biotech Conference. It's my great pleasure to have with me 3 distinguished management members: from Apellis, the CEO, Cedric Francois; from Editas Medicine, Charlie Albright, the Chief Scientific Officer; and of course, in the middle Raul Rodriguez, the President and CEO of Rigel Pharmaceuticals. So welcome all of you. Thanks for participating.
Questions & Answers
So maybe just to kick off, it would be very helpful since your -- I titled this benign hematology, but there's slight differences in the therapeutic focuses for all 3 of your companies. So maybe it would be helpful just to start out giving us a sense of the unmet need in PNH, in ITP and then in the hemoglobinopathies, beta thal and sickle cell just at a high level, that would be perfect.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
